| Primary |
| Product Used For Unknown Indication |
45.5% |
| Attempted Suicide |
9.1% |
| Gastroesophageal Reflux |
5.5% |
| Intentional Self-injury |
5.5% |
| Prophylaxis |
5.5% |
| Pulmonary Tuberculosis |
5.5% |
| Drug Use For Unknown Indication |
3.6% |
| Helicobacter Infection |
3.6% |
| Abdominal Pain Upper |
1.8% |
| Cardiovascular Event Prophylaxis |
1.8% |
| Gastroesophageal Reflux Disease |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Helicobacter Test Positive |
1.8% |
| Hiatus Hernia |
1.8% |
| Nausea |
1.8% |
| Oropharyngeal Pain |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
|
| Thrombocytopenia |
9.1% |
| Tubulointerstitial Nephritis |
9.1% |
| Human Herpesvirus 7 Infection |
4.5% |
| Hypersensitivity |
4.5% |
| Hypovolaemia |
4.5% |
| Inappropriate Antidiuretic Hormone Secretion |
4.5% |
| Intracardiac Thrombus |
4.5% |
| Laryngeal Oedema |
4.5% |
| Oedema |
4.5% |
| Pancreatitis Acute |
4.5% |
| Pernicious Anaemia |
4.5% |
| Product Substitution Issue |
4.5% |
| Productive Cough |
4.5% |
| Prurigo |
4.5% |
| Rash Erythematous |
4.5% |
| Rash Generalised |
4.5% |
| Skin Test Positive |
4.5% |
| Sopor |
4.5% |
| Speech Disorder |
4.5% |
| Suicide Attempt |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
36.7% |
| Prophylaxis |
8.2% |
| Acute Coronary Syndrome |
6.1% |
| Diabetes Mellitus |
6.1% |
| Gastric Resection |
6.1% |
| Analgesic Therapy |
4.1% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Suicide Attempt |
4.1% |
| Abdominal Discomfort |
2.0% |
| Amyloidosis |
2.0% |
| Anxiety |
2.0% |
| Asthma |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Depression |
2.0% |
| Dyslipidaemia |
2.0% |
| Gout |
2.0% |
| Hypertension |
2.0% |
| Muscle Contracture |
2.0% |
| Osteitis |
2.0% |
| Procedural Pain |
2.0% |
|
| Angioedema |
20.0% |
| Toxicity To Various Agents |
10.0% |
| Dry Mouth |
5.0% |
| Hepatitis |
5.0% |
| Hypertension |
5.0% |
| Hyponatraemia |
5.0% |
| Linear Iga Disease |
5.0% |
| Liver Function Test Abnormal |
5.0% |
| Pruritus |
5.0% |
| Rash Papular |
5.0% |
| Skin Disorder |
5.0% |
| Suicide Attempt |
5.0% |
| Toothache |
5.0% |
| Visual Acuity Reduced |
5.0% |
| Visual Impairment |
5.0% |
| Vomiting |
5.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.1% |
| Plasma Cell Myeloma |
15.4% |
| Multiple Sclerosis |
5.6% |
| Hypertension |
4.3% |
| Depression |
3.7% |
| Hodgkin's Disease |
3.7% |
| Prophylaxis |
3.7% |
| Actinic Keratosis |
3.1% |
| Chronic Myeloid Leukaemia |
3.1% |
| Immunodeficiency Common Variable |
3.1% |
| Nephrogenic Anaemia |
3.1% |
| Anaplastic Large-cell Lymphoma, Primary Systemic Type |
2.5% |
| Colorectal Cancer Metastatic |
2.5% |
| Oesophageal Adenocarcinoma |
2.5% |
| Osteoarthritis |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
| Atrial Fibrillation |
1.9% |
| B-cell Lymphoma |
1.9% |
| Duodenal Ulcer |
1.9% |
| Acute Myocardial Infarction |
1.2% |
|
| Vomiting |
15.8% |
| White Blood Cell Count Decreased |
8.8% |
| Vision Blurred |
7.0% |
| Rectal Haemorrhage |
5.3% |
| Renal Failure Acute |
5.3% |
| Renal Impairment |
5.3% |
| Thrombosis |
5.3% |
| Urinary Tract Infection |
5.3% |
| Cardiac Arrest |
3.5% |
| Fatigue |
3.5% |
| Leukocytoclastic Vasculitis |
3.5% |
| Malignant Neoplasm Progression |
3.5% |
| Nausea |
3.5% |
| Neutropenia |
3.5% |
| Off Label Use |
3.5% |
| Plasmacytoma |
3.5% |
| Pulmonary Thrombosis |
3.5% |
| Pyrexia |
3.5% |
| Rash |
3.5% |
| Red Blood Cell Count Decreased |
3.5% |
|
